Latest Breaking News On - Biocryst pharmaceuticals stock down - Page 1 : comparemela.com

Analysts Set BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Price Target at $14 00

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has received a consensus recommendation of “Buy” from the seven analysts that are currently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued a report on the stock in the last […]

Nancyj hutsonStevenk galsonInsider transactions at biocryst pharmaceuticalsInstitutional trading of biocryst pharmaceuticalsTower research capitalBiocryst pharmaceuticals company profileBiocryst pharmaceuticalsBiocryst pharmaceuticals stock downBiocryst pharmaceuticals incFifth third bancorpAnalyst recommendations for biocryst pharmaceuticalsSecurities exchange commissionThird bancorpNews ratings for biocryst pharmaceuticals dailyNeedham companyGet free report

BioCryst Pharmaceuticals (NASDAQ:BCRX) Announces Earnings Results

BioCryst Pharmaceuticals (NASDAQ:BCRX) Announces Earnings Results
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Biocryst pharmaceuticals company profileEarnings history for biocryst pharmaceuticalsBiocryst pharmaceuticals stock downBiocryst pharmaceuticalsBiocryst pharmaceuticals incNews ratings for biocryst pharmaceuticals dailyNeedham companyGet free reportCryst pharmaceuticals stock downCryst pharmaceuticalsBiocryst pharmaceuticals daily

BioCryst Pharmaceuticals (NASDAQ:BCRX) Price Target Raised to $15 00 at JMP Securities

BioCryst Pharmaceuticals (NASDAQ:BCRX) Price Target Raised to $15 00 at JMP Securities
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesChina universal asset management coBiocryst pharmaceuticals company profileInstitutional investors weigh in on biocryst pharmaceuticalsBiocryst pharmaceuticals stock downAnalyst recommendations for biocryst pharmaceuticalsTeza capital managementFifth third bancorpNews ratings for biocryst pharmaceuticals dailyThird bancorpBiocryst pharmaceuticalsBiocryst pharmaceuticals incNeedham companyGreat valley advisor group incGet free reportCryst pharmaceuticals stock down

BioCryst Pharmaceuticals (NASDAQ:BCRX) PT Raised to $15 00

BioCryst Pharmaceuticals (NASDAQ:BCRX) PT Raised to $15 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Recursos ltdaTower research capitalAnalyst recommendations for biocryst pharmaceuticalsFifth third bancorpNews ratings for biocryst pharmaceuticals dailyThird bancorpInstitutional trading of biocryst pharmaceuticalsChina universal asset management coBiocryst pharmaceuticalsBiocryst pharmaceuticals stock downBiocryst pharmaceuticals incNeedham companyGet free reportCryst pharmaceuticals stock downCryst pharmaceuticalsUniversal asset management

Jump Financial LLC Boosts Holdings in BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX)

Jump Financial LLC grew its position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 371.5% in the third quarter, according to its most recent filing with the SEC. The fund owned 404,913 shares of the biotechnology company’s stock after acquiring an additional 319,037 shares during the quarter. Jump Financial LLC’s holdings in […]

Biocryst pharmaceuticals stock downNeedham companyNews ratings for biocryst pharmaceuticals dailyJump financialVanguard group incBiocryst pharmaceuticals incQuarter for biocryst pharmaceuticalsMillennium managementBiocryst pharmaceuticalsJpmorgan chase coFree reportStreet corpCryst pharmaceuticals stock downCryst pharmaceuticalsGet free reportVisit holdingschannel